Submission Details
| 510(k) Number | K093233 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 14, 2009 |
| Decision Date | December 04, 2009 |
| Days to Decision | 51 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K093233 is an FDA 510(k) clearance for the D3 FASTPOINT L-DFA RSV/MVP IDENTIFICATION KIT, a Antisera, Fluorescent, Human Metapneumovirus (Class II — Special Controls, product code OMG), submitted by Diagnostic Hybrids, Inc. (Athens, US). The FDA issued a Cleared decision on December 4, 2009, 51 days after receiving the submission on October 14, 2009. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3980.
| 510(k) Number | K093233 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 14, 2009 |
| Decision Date | December 04, 2009 |
| Days to Decision | 51 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | OMG — Antisera, Fluorescent, Human Metapneumovirus |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3980 |
| Definition | It Is Intended For The Qualitative Detection And Identification Of Human Metapneumovirus (hmpv) In Direct Respiratory Specimens Or Cell Culture. The Assay Detects Hmpv Antigens By Immunofluorescence Using Antibodies, From Patients With Signs And Symptoms Of Acute Respiratory Infection. This Assay Detects But Is Not Intended To Differentiate The Four Recognized Genetic Sub-lineages Of Hmpv. |